|4Sep 12, 3:05 PM ET

Wong Hing C 4

4 · HCW Biologics Inc. · Filed Sep 12, 2022

Insider Transaction Report

Form 4
Period: 2022-09-08
Wong Hing C
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2022-09-08$2.67/sh+4,000$10,68015,300,468 total
  • Purchase

    Common Stock

    2022-09-09$2.70/sh+6,000$16,20015,306,468 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION